RenalGuard Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

RenalGuard General Information

Description

Developer of medical devices designed to treat cardiac and vascular-related ailments. The company's devices rapidly removes contrast dyes that are known to be toxic to the kidneys to minimize the risk of under-hydration while maintaining the high urine flows recommended for the prevention of cervical intraepithelial neoplasm, enabling clinical practitioners to treat their patients suffering from acute renal failure in an improved way.

Contact Information

Website
cardiorenalsystems.com
Formerly Known As
PLC Systems
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 459 Fortune Boulevard
  • Milford, MA 01757
  • United States
+1 (508)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 459 Fortune Boulevard
  • Milford, MA 01757
  • United States
+1 (508)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RenalGuard Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC Completed Generating Revenue
4. Early Stage VC 12-Sep-2018 Completed Startup
3. Early Stage VC (Series A) 16-Mar-2017 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Buyout/LBO 14-May-2014 Completed Startup
To view RenalGuard’s complete valuation and funding history, request access »

RenalGuard Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Series A1
To view RenalGuard’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

RenalGuard Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices designed to treat cardiac and vascular-related ailments. The company's devices rapidly remo
Therapeutic Devices
Milford, MA
35 As of 2025

Danvers, MA
 

Vapi, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RenalGuard Competitors (14)

One of RenalGuard’s 14 competitors is Abiomed, a Corporate Backed or Acquired company based in Danvers, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abiomed Corporate Backed or Acquired Danvers, MA
Meril Life Sciences Private Equity-Backed Vapi, India
Boston Scientific Corporation Marlborough, MA
Vascular Concepts Private Equity-Backed Bangalore, India
Barostim Formerly VC-backed Minneapolis, MN
You’re viewing 5 of 14 competitors. Get the full list »

RenalGuard Patents

  • 33

    Total Documents Applications and Grants

  • Total Patents Families

  • 29

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

RenalGuard Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10881774-B2 Method and system to protect kidneys during surgery Inactive 23-Sep-2016
US-12064541-B2 Method and system to protect kidneys during surgery Active 23-Sep-2016
US-20180085510-A1 Method and system to protect kidneys during surgery Active 23-Sep-2016
US-20210113754-A1 Method and system to protect kidneys during surgery Active 23-Sep-2016
US-10639419-B2 Fluid therapy method Active 17-Mar-2014 A61M5/1723
To view RenalGuard’s complete patent history, request access »

RenalGuard Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RenalGuard Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abiomed Corporation Minority
Exigent Capital Group Merchant Banking Firm Minority
Genesis Capital Advisors (New York) PE/Buyout Majority
Coridea VC-Backed Company
Kidron Venture Capital Minority
To view RenalGuard’s complete investors history, request access »

Ready to get started?

Request a free trial

RenalGuard FAQs

  • When was RenalGuard founded?

    RenalGuard was founded in 2014.

  • Where is RenalGuard headquartered?

    RenalGuard is headquartered in Milford, MA.

  • What is the size of RenalGuard?

    RenalGuard has 35 total employees.

  • What industry is RenalGuard in?

    RenalGuard’s primary industry is Therapeutic Devices.

  • Is RenalGuard a private or public company?

    RenalGuard is a Private company.

  • What is RenalGuard’s current revenue?

    The current revenue for RenalGuard is .

  • How much funding has RenalGuard raised over time?

    RenalGuard has raised $21.5M.

  • Who are RenalGuard’s investors?

    Abiomed, Exigent Capital Group, Genesis Capital Advisors (New York), Coridea, and Kidron have invested in RenalGuard.

  • Who are RenalGuard’s competitors?

    Abiomed, Meril Life Sciences, Boston Scientific, Vascular Concepts, and Barostim are some of the 14 competitors of RenalGuard.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »